Zhiping Qian

2.1k total citations · 1 hit paper
38 papers, 1.4k citations indexed

About

Zhiping Qian is a scholar working on Epidemiology, Surgery and Immunology. According to data from OpenAlex, Zhiping Qian has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 12 papers in Surgery and 10 papers in Immunology. Recurrent topics in Zhiping Qian's work include COVID-19 Clinical Research Studies (8 papers), Liver Disease and Transplantation (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). Zhiping Qian is often cited by papers focused on COVID-19 Clinical Research Studies (8 papers), Liver Disease and Transplantation (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). Zhiping Qian collaborates with scholars based in China, United States and Spain. Zhiping Qian's co-authors include Hongzhou Lu, Yuyi Zhang, Yun Ling, Tao Li, Jun Chen, Shuibao Xu, Tangkai Qi, Tongyu Zhu, Li Liu and Yinzhong Shen and has published in prestigious journals such as Circulation, The Journal of Immunology and PLoS ONE.

In The Last Decade

Zhiping Qian

38 papers receiving 1.3k citations

Hit Papers

Clinical progression of p... 2020 2026 2022 2024 2020 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhiping Qian China 17 577 275 242 237 213 38 1.4k
Zhiwei Li China 17 691 1.2× 319 1.2× 375 1.5× 489 2.1× 82 0.4× 72 1.6k
Pavan K. Bendapudi United States 18 714 1.2× 330 1.2× 187 0.8× 205 0.9× 604 2.8× 56 2.0k
Man Fai Lam China 26 306 0.5× 107 0.4× 296 1.2× 160 0.7× 285 1.3× 54 1.8k
Gwilym J. Webb United Kingdom 24 431 0.7× 137 0.5× 482 2.0× 723 3.1× 301 1.4× 56 1.8k
Nicholas Bandarenko United States 19 145 0.3× 143 0.5× 328 1.4× 109 0.5× 697 3.3× 36 1.9k
Ki‐Seong Eom South Korea 25 140 0.2× 107 0.4× 95 0.4× 242 1.0× 583 2.7× 188 2.3k
Stephen P. McAdoo United Kingdom 27 549 1.0× 174 0.6× 203 0.8× 142 0.6× 643 3.0× 103 2.5k
Matthias Schaier Germany 23 258 0.4× 60 0.2× 194 0.8× 153 0.6× 690 3.2× 72 1.8k
Edmund Huang United States 28 161 0.3× 82 0.3× 798 3.3× 177 0.7× 217 1.0× 85 2.0k
Furong Zeng China 22 538 0.9× 258 0.9× 148 0.6× 182 0.8× 212 1.0× 69 1.9k

Countries citing papers authored by Zhiping Qian

Since Specialization
Citations

This map shows the geographic impact of Zhiping Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiping Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiping Qian more than expected).

Fields of papers citing papers by Zhiping Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiping Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiping Qian. The network helps show where Zhiping Qian may publish in the future.

Co-authorship network of co-authors of Zhiping Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiping Qian. A scholar is included among the top collaborators of Zhiping Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiping Qian. Zhiping Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Hui, Hai Li, Guohong Deng, et al.. (2025). A novel model for identifying infections in patients with AoCLD: a nationwide, multicenter, prospective cohort study. QJM. 118(7). 489–500. 1 indexed citations
3.
You, Qingmin, et al.. (2025). Caloneis nanyiensis sp. nov. (Bacillariophyta) from Nanyi Lake of Anhui Province, China. PhytoKeys. 255. 113–122. 1 indexed citations
4.
Liu, Huimin, Hai Li, Guohong Deng, et al.. (2024). Association of AST/ALT ratio with 90-day outcomes in patients with acute exacerbation of chronic liver disease: a prospective multicenter cohort study in China. Frontiers in Medicine. 11. 1307901–1307901. 10 indexed citations
5.
Li, Hai, Guohong Deng, Xianbo Wang, et al.. (2024). sTREM-1 as promising prognostic biomarker for acute-on-chronic liver failure and mortality in patients with acute decompensation of cirrhosis. World Journal of Gastroenterology. 30(9). 1177–1188. 1 indexed citations
6.
Wang, Xianbo, Guohong Deng, Yan Huang, et al.. (2021). Cohort profile: a multicentre prospective validation cohort of the Chinese Acute-on-Chronic Liver Failure (CATCH-LIFE) study. BMJ Open. 11(1). e037793–e037793. 6 indexed citations
7.
Wang, Zhenyan, Jun Chen, Li Liu, et al.. (2021). Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients. Frontiers in Immunology. 12. 568789–568789. 13 indexed citations
8.
Zhang, Xiaoyu, et al.. (2021). Analysis of the Effect of Proton-Pump Inhibitors on the Course of COVID-19. Journal of Inflammation Research. Volume 14. 287–298. 3 indexed citations
9.
Xue, Mei, Yuyi Zhang, Hui Zhu, et al.. (2020). Observations about symptomatic and asymptomatic infections of 494 patients with COVID-19 in Shanghai, China. American Journal of Infection Control. 48(9). 1045–1050. 22 indexed citations
10.
Chen, Jun, Zebing Huang, Hai Li, et al.. (2020). Early Diagnostic Biomarkers of Sepsis for Patients with Acute-on-Chronic Liver Failure: A Multicenter Study. Infectious Diseases and Therapy. 10(1). 281–290. 27 indexed citations
11.
Ling, Yun, Zhiping Qian, Dan Huang, et al.. (2020). Clinical analysis of risk factors for severe patients with novel coronavirus pneumonia. 38(12). 11 indexed citations
12.
Chen, Jun, Tangkai Qi, Li Liu, et al.. (2020). Clinical progression of patients with COVID-19 in Shanghai, China. Journal of Infection. 80(5). e1–e6. 582 indexed citations breakdown →
13.
Cheng, Wenjuan, Yutang Wang, Zhiping Qian, et al.. (2017). The association between serum uric acid and blood pressure in different age groups in a healthy Chinese cohort. Medicine. 96(50). e8953–e8953. 30 indexed citations
14.
Chen, Mingquan, Jianbin Zhang, Ning Li, et al.. (2011). Promoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer. PLoS ONE. 6(10). e25564–e25564. 129 indexed citations
15.
Gao, Fabao, Jiangyang Zhang, Bensheng Qiu, et al.. (2007). MRI of intravenously injected bone marrow cells homing to the site of injured arteries. NMR in Biomedicine. 20(7). 673–681. 16 indexed citations
16.
Ota, Hirofumi, Karen Fox-Talbot, Weimin Hu, et al.. (2005). Terminal Complement Components Mediate Release of von Willebrand Factor and Adhesion of Platelets in Arteries of Allografts. Transplantation. 79(3). 276–281. 29 indexed citations
17.
Nakashima, Shinji, Zhiping Qian, Siavash Rahimi, B Wa̧sowska, & William M. Baldwin. (2002). Membrane Attack Complex Contributes to Destruction of Vascular Integrity in Acute Lung Allograft Rejection. The Journal of Immunology. 169(8). 4620–4627. 62 indexed citations
18.
Chen, Weiran, Christopher J. Thoburn, Yuji Miura, et al.. (2001). Autoimmune-Mediated Vasculopathy. Clinical Immunology. 100(1). 57–70. 15 indexed citations
19.
Qian, Zhiping, et al.. (2001). ACCELERATED GRAFT ARTERIOSCLEROSIS IN CARDIAC TRANSPLANTS. Transplantation. 72(5). 900–906. 31 indexed citations
20.
Tierney, Sean, Zhiping Qian, Pamela A. Lipsett, Henry A. Pitt, & Keith D. Lillemoe. (1998). Ethanol inhibits sphincter of Oddi motility. Journal of Gastrointestinal Surgery. 2(4). 356–362. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026